16th ICNA Conference • ICNA • International Conference on Neuroprotective Agents

16th International Conference on Neuroprotective Agents

When?

23-26 September 2024

Location

Home 2 Suites by Hilton, 3100 SE E Pointe Ave, Bentonville, AR 72712

Registration fees

Regular – $400.00
In -Training $200.00
After July 5th
Regular – $500.00
In -Training $250.00

Registration fees can be paid by bank transfer (bank fees paid by the registrant), credit card or debit card.

The registration fee is the same for a presenter and a guest including students (in training). A letter from the training program director required for student/in-training discounts:

Registration fee includes:

Participation in the on-site congress
Access to the scientific content
Access to the on-site posters area
Reception Monday, lunch and dinner Tuesday and Wednesday (breakfast included with hotel).
Refreshment breaks as per times scheduled in the scientific program

Registration Fees	In-person	In-person student	Virtual	Virtual student
Early (by July 5)	350 euro	175 euro	50 euro	25 euro
Late	450 euro	225 euro	100 euro	50 euro

Cancellation

Changes and Cancellation (all to be made by email to [email protected]):

Registration fee can be fully refunded (less any bank charges) if requested within 14 days (early registration – July 19)
Refund of registration fee (minus 100 dollars processing fee) will be granted until August 15.
After August 15, a 50% refund will be granted.
After September 5, no refund will be granted.

Lodging fees

Lodging fees can be arranged directly with Home 2 Suites by Hilton for all except those qualifying for the student/in-training discount. Those requesting a student or in-training discount (letter from training program director required), please contact Bill Slikker.

* Room rates: studio king suite & studio two queen suite ($169 for either room)

Lodging Fees	In-person (per night)	In-person student (per night)
Early (by July 5)	87/97/102/112* EUR	45/50/55/60* EUR
Late (by Aug 15)	100/110/115/125* EUR	50/55/60/65* EUR
After Aug 15	same as “late” if available	same as “late” if available

Abstract Deadline

Abstract submission is by email attachment. Please send your email with abstract attached to Russell Andrew ([email protected]) and William Slikker ([email protected]). Abstracts should be submitted as a Word document, including author(s), affiliation(s), abstract (250 word maximum) and choice of oral or poster presentation. Final decision regarding oral versus poster presentation will be up to the organizers. Deadline for abstract submission is June 14. Notification of acceptance will be before the deadline for early registration. Any registrant whose abstract is not accepted can receive a full refund of the early registration fee if they decide not to attend because of abstract rejection.

Oral Presentations

To make an oral presentation, one must be registered for the 16th ICNA. Presenters who have not registered by August 15 may not be included in the final presentation schedule.

Facilities will be available for Powerpoint presentations, with a strict maximum of 15 minutes. It is recommended that the presentation be limited to 12 minutes to allow time for some discussion. Each session will also conclude with 15 minutes for general discussion.

Deadline summary
Abstract submission	June 14, 2024
Early registration	July 5, 2024
Early lodging	July 5, 2024
Late registration	After July 5th, 2024
Late lodging	After July 5th, 2024

Logistic Partner

Bill Slikker; E-mail: [email protected]

Welcome to Bentonville!!

Those who have participated in a previous ICNA can attest to how enjoyable and educational the ICNA meeting is. It is a unique opportunity to meet colleagues and establish new professional relationships in a vacation-like environment. Welcome to Bentonville!!

Northwest Arkansas Airport (XNA) is the airport in closest proximity to the meeting venue.

Local Activities:
https://www.safdiearchitects.com/projects/crystal-bridges-museum-of-american-art-expansion
https://www.instagram.com/reel/C6hf9s2OQGT/?igsh=MTc5cmJ5cjZkcjAwag==

Guided Exhibits:
Knowing the West | Crystal Bridges Museum of American Art
Frank Lloyd Wright Tours | Crystal Bridges Museum of American Art

Scientific & Social Program

Program times refer to US Central Time (GMT-5)

Monday, 23rd September (Day 1)

15:00 - 20:30

Tuesday, 24th September (Day 2)

07:30 - 21:30

07:30-08:30 | Breakfast
Session 1 | Moderator: Tucker Patterson (USA)
08:30-08:45 | Welcome address | Dafin Muresanu (Romania), William Slikker (USA), Russell Andrews (USA)
08:45-09:00 | Gu Q. (USA) | Combine tissue-clearing and Fluoro-Jade C labeling for neurotoxicity assessments
09:00-09:15 | Zhang X. (USA) | Discontinuation of Methylphenidate after Long-term Exposure in Nonhuman Primates
09:15-09:30 | Liu F. (USA) | Establishment of Neural Stem Cells from Fetal Monkey Brain for Neurotoxicity Testing
09:30-09:45 | Wang C. (USA) | Development of a Primate Model to Evaluate the Effects of Ketamine and Surgical Stress on the Neonatal Brain
09:45-10:00 | Muresanu D. (Romania) | The Concept of Neurobiological Reserve – A Gateway to Brain Recovery
10:00-10:15 Fisher M. (USA) | New treatments in cerebrovascular diseases
10:15-10:30 Coffee Break
Session 2 | Moderator: William Slikker (USA)
10:30-10:45 | Todorovic S. (USA) | Neonatal ketamine and 3b-OH exposure differently affect neuronal oscillations and synaptic plasticity in the subiculum but do not alter sleep macrostructure in adolescent rats
10:45-11:00 | Morgan F. (USA) | Tetraethylammonium Chloride as an Inhibitor of Anaesthetic-Induced Neurotoxicity Across Species
11:00-11:15 | Jevtovic-Todorovic V. (USA) | Anesthesia-induced developmental neurotoxicity: Is it time for a new anesthetic?
11:15-11:30 | Andrews R. (USA) | Exosomes: Nano-sized Neuroprotective Agents
11:30-11:45 | Figueiredo T. (USA) | Neuroprotective efficacy of midazolam in comparison with an antiglutamatergic therapy in immature rats exposed to the nerve agent soman
11:45-12:00 Discussions
12:00-13:00 Lunch Break
Session 3 | Moderator: Slobodan Todorovic (USA)
13:00-13:15 | Perouanski M. (USA) | Mitochondrial Complex I function may be critical for preconditioning-based neuroprotection in a Drosophila model of anesthetic neurotoxicity
13:15-13:30 | Sedensky M. (USA) | Developmental Dependence of Anesthetic Induced Toxicity in a Mouse Model of Mitochondrial Disease
13:30-13:45 | Requejo C. (Spain) | TiO2-nanowired-cerebrolysin delivery restores the metabolic dysregulation of the basal ganglia in a 6-OHDA rat model of Parkinson’s disease
13:45-14:00 | Vaquero-Rodríguez A. (Spain) | A Neuroprotective strategy improving morpho-functional changes in alpha-synuclein rat model of parkinson's disease
14:00-14:15 | Iker B. (Spain) | Interneurons under ketamine – fluoxetine administration in an animal model of depression
14:15-14:30 Discussions
14:30-14:45 Coffee Break
Session 4
14:45-16:00 | Poster session
16:00-17:00 | ICNA Business Meeting: Open access
17:30-19:00 Cluj City tour
20:00-21:30 Dinner at Grand Hotel Italia

Wednesday, 25th September (Day 3)

07:30 - 20:30

07:30-08:30 | Breakfast
Session 5 | Moderator: Russell Andrews (USA)
08:30-08:45 | Russomano T. (Romania/UK) | Medical Challenges & Achievements in Space Missions
08:45-09:00 | Russomano T. (Romania/UK) | Humans in Space – A Research & Educational Network
09:00-09:15 | Torrinha G. (Portugal) | Structural changes in Brain MRI due to Head Down Tilt Bed Rest (Systematic Review and Future Research Guidelines)
09:15-09:30 | Félix H. (Portugal) | Non-invasive Intracranial Pressure Monitoring and Its Applicability in Spaceflight
09:30-09:45 | Figueiredo J. (USA) | Influence of repeated exposures to variations of G accelerations in the cerebral autoregulatory mechanisms in high performance pilots
09:45-10:00 Discussions
10:00-10:30 Coffee Break
Session 6 | Moderator: Vesna Jevtovic-Todorovic (USA)
10:30-10:45 | Hynynen K. (Canada) | MRI–guided focused ultrasound for precise modulation of BBB for targeted therapy
10:45-11:00 | Oxenkrug G. (USA) | Extension of life span by down-regulation of tryptophan conversion into kynure-nine and its neurotoxic catabolites: towards the kynurenine hypothesis of aging
11:00-11:15 | Wei H. (USA) | Muscle Relaxant Dantrolene Repurposed to Treat Alzheimer’s Disease
11:15-11:30 | Khan T. (Pakistan) | Neurotrauma Management in Low- and Middle-Income Countries
11:30-11:45 | Andrews R. (USA) | Neuroprotective Agents Beyond the Nervous System
11:45-12:00 Discussions
12:00-13:00 Lunch Break
13:45 Depart by bus for Turda
14:30 - 17:30 Salt Mine Tour
18:00-20:30 Dinner at Hunter Prince Castle

Thursday, 26th September (Day 4)

07:30 - 12:15

07:30-08:30 | Breakfast
Session 7 | Moderator: Damien Kuffler (Puerto Rico)
08:30-08:45 | Ashraf M. (UK) | Traumatic Brain Injury in Underage Motorcyclists: Clinical Outcomes and Socio-Cultural Attitudes from a Lower-Middle-Income Country
08:45-09:00 | Lin A. (Taiwan) | Oral Ellagic Acid Attenuated LPS-induced Neuroinflammation in Rat Brain: The Involvement of MEK-ERK Signaling and M2 Microglial
09:00-09:15 | Kuffler D. (Puerto Rico) | Platelet-Rich Plasma as a Means of Reducing/Eliminating Phantom Limb Pain?
09:15-09:30 | Marini A. (USA) | Alpha-linolenic acid (ALA) facilitates GABAergic synaptic transmission in the basolateral amygdala and CA1 hippocampal region: a mechanism to reduce hyperexcitability
09:30-09:45 | Saberi H. (Iran) | Granulocyte-colony stimulating factor administration for neurological improvement in patients with post-rehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial - long term follow up and possible indications
09:45-10:00 Discussions
10:00-10:15 Closing Statements